Picture of TCR2 Therapeutics logo

TCRR TCR2 Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

U.S. STOCKS ON THE MOVE-Airlines, Thor Industries, TCR2 Therapeutics

* 
      Eikon search string for individual stock moves:  STXBZ 
    

        * 
      The Day Ahead newsletter: https://refini.tv/3LI4BU7
    

        * 
      The Morning News Call newsletter: https://refini.tv/3dKUyB8
    

  
U.S. stock index futures signaled shares would extend their sharp selloff on
Wednesday, as they dropped after a report said tech major Apple had shelved its
plan to increase production of its new iPhones on weak demand.  .N 
    At 9:07 a.m. ET, Dow e-minis  1YMc1  were up 0.44% at 29,331. S&P 500
e-minis  ESc1  were up 0.30% at 3,672, while Nasdaq 100 e-minis  NQc1  were
unchanged at 11,334.25.
 
 The top three NYSE percentage gainers premarket  .PRPG.NQ :
 ** Onion Global Ltd  OG.N , up 23.1%
 ** Solo Brands Inc  DTC.N , up 12.4%
 ** Annovis Bio Inc  ANVS.N , up 9.3%
 
 The top three NYSE percentage losers premarket  .PRPL.NQ :
 ** First High School Education Group Co Ltd  FHS.N , down 11%
 ** Sandstorm Gold Ltd  SAND.N , down 9.3%
 ** Equitrans Midstream Corp  ETRN.N , down 8.7%
 
 The top three Nasdaq percentage gainers premarket  .PRPG.O :
 ** Atlis Motor Vehicles Inc  AMV.O , up 192.3%
 ** Acumen Pharmaceuticals Inc  ABOS.O , up 86.2%
 
 The top two Nasdaq percentage losers premarket  .PRPL.O :
 ** Mind Medicine (MindMed) Inc  MNMD.O , down 51%
 ** Phasebio Pharmaceuticals Inc  PHAS.O , down 47.4%
 
 ** Generac Holdings Inc  GNRC.N : up 0.7% premarket
 BUZZ - Jefferies initiates coverage on Generac with 'hold' rating  urn:newsml:reuters.com:*:nL4N30Z1YU
 
 ** Biogen Inc  BIIB.O : up 49.1% premarket
 BUZZ - Alzheimer's drug developers soar after Biogen's "unequivocal win"
 urn:newsml:reuters.com:*:nL4N30Z2FR
 ** Aptiv PLC  APTV.N : up 0.8% premarket
 BUZZ - Berenberg assumes coverage on Aptiv with 'buy' rating  urn:newsml:reuters.com:*:nL4N30Z234
 ** Apple Inc  AAPL.O : down 2.3% premarket
 BUZZ - Fall on report of co's dropped production boost plan  urn:newsml:reuters.com:*:nL4N30Z2R3
 ** Mind Medicine Inc  MNMD.O : down 51.0% premarket
 BUZZ - Plunges on deep-discounted stock-and-warrants deal  urn:newsml:reuters.com:*:nL1N30Z0RT
 ** Teladoc Health Inc  TDOC.N : up 0.6% premarket
 BUZZ - Slides as RBC raises near-term growth concerns  urn:newsml:reuters.com:*:nL4N30Z2JG
 ** BlackBerry Ltd  BB.N : down 3.7% premarket
 BUZZ - Falls on PT cuts after results  urn:newsml:reuters.com:*:nL4N30Z2MX 
 ** Lyft Inc  LYFT.O : down 1.1% premarket
 BUZZ - Freezes U.S. hiring through end of year, shares slide  urn:newsml:reuters.com:*:nL4N30Z2NM 
 ** Ocugen Inc  OCGN.O : up 13.7% premarket
 BUZZ - Up on COVID vaccine deal with Washington University  urn:newsml:reuters.com:*:nL4N30Z2O7 
 ** Beauty Health Co  SKIN.O : up 3.4% premarket
 BUZZ - D.A. Davidson raises BeautyHealth's PT after co's share repurchase
authorization  urn:newsml:reuters.com:*:nL4N30Z2GY 
 ** T-Mobile US Inc  TMUS.O : up 1.6% premarket
 BUZZ - Scotiabank raises PT on T-Mobile, favors co as top pick in U.S.
 urn:newsml:reuters.com:*:nL4N30Z2OD 
 ** Gamida Cell Ltd  GMDA.O : down 25.0% premarket
 BUZZ - Slides on pricing $20 mln share offering  urn:newsml:reuters.com:*:nL1N30Z0VX 
 ** Thor Industries Inc  THO.N : up 3.8% premarket
 BUZZ - Up on strong Q4 results  urn:newsml:reuters.com:*:nL4N30Z2VC
** American Airlines Group Inc  AAL.O : up 0.2% premarket
** Southwest Airlines Co  LUV.N : up 0.2% premarket
** JetBlue Airways Corp  JBLU.O : up 0.4% premarket   
** Delta Air Lines Inc  DAL.N : up 0.1% premarket
 BUZZ - U.S. airlines cancel over 2,000 flights due to Hurricane Ian
 urn:newsml:reuters.com:*:nL4N30Z2X0
 ** TCR2 Therapeutics Inc  TCRR.O : up 14.2% premarket
 BUZZ - Up on promising data from cancer therapy  urn:newsml:reuters.com:*:nL4N30Z2Y5
 ** Cognyte Software Ltd  CGNT.O : down 9.1% premarket
 BUZZ - Tumbles on Q2 revenue miss  urn:newsml:reuters.com:*:nL4N30Z2Y1
 (Compiled by Rajarshi Roy and Yuvraj Malik)
 ((Yuvraj.malik@thomsonreuters.com))

Recent news on TCR2 Therapeutics

See all news